Public Release Type:
Journal
Publication Year: 2011
DOI:
https://doi.org/10.1002/hep.24666
Authors:
Navarro VJ,
Afdhal NH,
Belle SH,
Doo EC,
Fried MW,
Hawke RL,
Meyers CM,
Reddy KR,
The SYNCH Study Group,
Wahed AS
Studies:
Silymarin Trial for Hepatitis C and NASH
The botanical extract silymarin, commonly known as milk thistle, is a polyphenolic flavonoid with anti-oxidant, anti-inflammatory, and immunomodulatory properties in vitro and is used extensively by patients with chronic liver disease. This trial evaluated the effect of high doses of oral silymarin on disease activity in patients with chronic hepatitis C.